PharmaSGP Holding SE (PSG) — Capital Reinvestment Ratio

Latest as of March 2025: 0.17x

PharmaSGP Holding SE (PSG) has a Capital Reinvestment Ratio of 0.17x as of March 2025, meaning it reinvests 0% of its operating cash flow (€4.22 Million) in capital expenditures (€708.00K). See PharmaSGP Holding SE balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.17x
Capex / Operating Cash Flow

Operating Cash Flow

€4.22 Million
EUR

Capital Expenditures

€708.00K
EUR

Data as of

Mar 2025
Most recent filing

PharmaSGP Holding SE Capital Reinvestment Ratio (2014–2024)

This chart tracks PharmaSGP Holding SE's Capital Reinvestment Ratio across 11 annual periods. Check PharmaSGP Holding SE investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for PharmaSGP Holding SE (2014–2024)

Year-by-year Capital Reinvestment Ratio for PharmaSGP Holding SE from 2014 to 2024. For live market cap and broader valuation context, see market value of PharmaSGP Holding SE.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.06x €24.88 Million €1.47 Million ▲ +82.0%
2023 0.03x €26.64 Million €866.00K ▲ +569.5%
2022 0.00x €24.71 Million €120.00K ▼ -36.8%
2021 0.01x €12.24 Million €94.00K ▼ -71.7%
2020 0.03x €15.46 Million €420.00K ▲ +14.1%
2019 0.02x €17.63 Million €420.00K ▼ -26.7%
2018 0.03x €8.43 Million €274.00K ▲ +16.7%
2017 0.03x €14.25 Million €397.00K ▼ -99.2%
2016 3.35x €3.55 Million €11.88 Million ▲ +731.2%
2015 0.40x €10.59 Million €4.26 Million ▲ +8.4%
2014 0.37x €5.41 Million €2.01 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow